This panel is to be applied to patients with syndromic congenital heart disease under 1 year of age.
This is a place-holder for a new gene panel that is currently in progress. Relevant genes can be added to the panel by reviewers, or if you have a gene list please contact [email protected].
Eligibility statement for Syndromic congenital heart disease (42213):
Syndromic congenital heart disease inclusion criteria (42218)
Congenital heart disease, AND
One or more malformations outside the cardiovascular system or neurodevelopmental delay
Syndromic congenital heart disease exclusion criteria (42218)
Recognised syndromic presentation (e.g. Noonan syndrome)
Likely causative environmental insult during gestation
Prior genetic testing guidance (42218)
- Results should have been reviewed for all genetic tests undertaken, including disease-relevant genes in exome sequencing data. The patient is not eligible if they have a molecular diagnosis for their condition.
- Genetic testing should continue according to routine local practice for this phenotype regardless of recruitment to the project; results of these tests must be submitted via the ‘Genetic investigations’ section of the data capture tool to allow comparison of WGS with current standard testing.
PLEASE NOTE: The sensitivity of WGS compared to current diagnostic genetic testing has not yet been established. It is therefore important that tests which are clinically indicated under local standard practice continue to be carried out.
Syndromic congenital heart disease prior genetic testing genes (42218)
Testing of the following genes should be carried out PRIOR TO RECRUITMENT where this is in line with current local practice:
Microarray genome wide copy number analysis; further testing as dictated by phenotype
Closing statement (42218)
These requirements will be kept under continual review during the main programme and may be subject to change.